A Phase II Study Evaluating Fostamatinib for Hospitalized Adults With COVID-19
Latest Information Update: 21 Jul 2022
At a glance
- Drugs Fostamatinib (Primary)
- Indications COVID 2019 infections; COVID-19 respiratory infection
- Focus Adverse reactions
- 01 Sep 2021 Results assessing safety of fostamatinib treatment in hospitalized patients with covid-19 published in the Clinical Infectious Diseases
- 01 Sep 2021 According to a Rigel Pharmaceuticals media release, results from this trial were published in the Clinical Infectious Diseases.
- 01 Sep 2021 Results published in the Rigel Pharmaceuticals Media Release.